We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide (CO)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2012 by CAN WANG, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT01818843
First Posted: March 27, 2013
Last Update Posted: March 28, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Information provided by (Responsible Party):
CAN WANG, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
February 26, 2013
March 27, 2013
March 28, 2013
April 2012
January 2013   (Final data collection date for primary outcome measure)
Number of participants with adverse events [ Time Frame: up to 1 month ]
Same as current
Complete list of historical versions of study NCT01818843 on ClinicalTrials.gov Archive Site
Not Provided
Number of participants with adverse events [ Time Frame: up to 1 month ]
Not Provided
Number of participants with adverse events [ Time Frame: up to 1 month ]
 
The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide
Phase 1 Study of Inhaled Carbon Monoxide on the Effectiveness of Neonatal Pulmonary Hypertension
Based on the study about carbon monoxide in human inflammatory and other beneficial physiological function , now we'll be going to research its application in neonates .Phase 1 Study as a foundation for the further test is, the safety and Adverse reaction study of newborn to inhaled CO
Previous studies have demonstrated that, carbon monoxide has showed the effectiveness such as in inflammation ,apoptosis as well as relaxation of smooth muscle of the body. Now we have a hypothesis to use carbon monoxide in pulmonary hypertension of the newborns, to observe whether it will decrease pulmonary artery hypertension on newborns. Phase 1 study is ,the safety and Adverse reaction study of newborn to inhaled CO , after this,we can master the application of carbon monoxide dose
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Miscellaneous Disorders in the Fetus or Newborn
Other: Inhaled Carbon Monoxide
Inhaled Carbon Monoxide in newborn
Experimental: Safety and Adverse Reaction in CO
Inhaled Carbon Monoxide
Intervention: Other: Inhaled Carbon Monoxide
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
24
December 2013
January 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • The newborn whose physiological function is healthy or close to healthy

Exclusion Criteria:

  • Clinical considerations cannot survive or no treatment value of newborn Diagnosis of congenital or hereditary diseases, or children with heart diseaseCentral pulmonary vascular malformations in children
Sexes Eligible for Study: All
up to 1 Month   (Child)
Yes
Contact information is only displayed when the study is recruiting subjects
China
 
 
NCT01818843
DapingH 021
Yes
Not Provided
Not Provided
CAN WANG, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
CAN WANG
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not Provided
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP